Determinants of intention to get vaccinated against COVID-19 among healthcare personnel in hospitals in Greece.


Journal

Infection, disease & health
ISSN: 2468-0869
Titre abrégé: Infect Dis Health
Pays: Netherlands
ID NLM: 101689703

Informations de publication

Date de publication:
08 2021
Historique:
received: 11 01 2021
revised: 19 03 2021
accepted: 25 03 2021
pubmed: 29 4 2021
medline: 10 7 2021
entrez: 28 4 2021
Statut: ppublish

Résumé

To investigate intention rates to get vaccinated against COVID-19 among healthcare personnel (HCP) in Greece. Cross-sectional survey. The response rate was 14.5%. Of 1521 HCP with a known profession, 607 (39.9%) were nursing personnel, 480 (31.6%) physicians, 171 (11.2%) paramedical personnel, 72 (4.7%) supportive personnel, and 191 (12.6%) administrative personnel. Overall, 803 of 1571 HCP (51.1%) stated their intention to get vaccinated while 768 (48.9%) stated their intention to decline vaccination. Most HCP (71.3%) who reported intent to get vaccinated noted contributing to the control of the pandemic and protecting their families and themselves as their reasons, while the most common reason for reporting intent to decline vaccination was inadequate information about the vaccines (74.9%), followed by concerns about vaccine safety (36.2%). Logistic regression analysis revealed that the probability of intending to get vaccinated increased with male gender, being a physician, history of complete vaccination against hepatitis B, history of vaccination against pandemic A (H1N1) in 2009-2010, belief that COVID-19 vaccination should be mandatory for HCP, and increased confidence in vaccines in general during the COVID-19 pandemic. The following factors were associated with a lower intention to get vaccinated: no vaccination against influenza the past season, no intention to get vaccinated against influenza in 2020-2021, and no intention to recommend COVID-19 vaccination to high-risk patients. There is an urgent need to built safety perception towards COVID-19 vaccines and raise vaccine uptake rates by HCP, and thus to protect the healthcare workforce and the healthcare services.

Sections du résumé

BACKGROUND
To investigate intention rates to get vaccinated against COVID-19 among healthcare personnel (HCP) in Greece.
METHODS
Cross-sectional survey.
RESULTS
The response rate was 14.5%. Of 1521 HCP with a known profession, 607 (39.9%) were nursing personnel, 480 (31.6%) physicians, 171 (11.2%) paramedical personnel, 72 (4.7%) supportive personnel, and 191 (12.6%) administrative personnel. Overall, 803 of 1571 HCP (51.1%) stated their intention to get vaccinated while 768 (48.9%) stated their intention to decline vaccination. Most HCP (71.3%) who reported intent to get vaccinated noted contributing to the control of the pandemic and protecting their families and themselves as their reasons, while the most common reason for reporting intent to decline vaccination was inadequate information about the vaccines (74.9%), followed by concerns about vaccine safety (36.2%). Logistic regression analysis revealed that the probability of intending to get vaccinated increased with male gender, being a physician, history of complete vaccination against hepatitis B, history of vaccination against pandemic A (H1N1) in 2009-2010, belief that COVID-19 vaccination should be mandatory for HCP, and increased confidence in vaccines in general during the COVID-19 pandemic. The following factors were associated with a lower intention to get vaccinated: no vaccination against influenza the past season, no intention to get vaccinated against influenza in 2020-2021, and no intention to recommend COVID-19 vaccination to high-risk patients.
CONCLUSION
There is an urgent need to built safety perception towards COVID-19 vaccines and raise vaccine uptake rates by HCP, and thus to protect the healthcare workforce and the healthcare services.

Identifiants

pubmed: 33906828
pii: S2468-0451(21)00017-1
doi: 10.1016/j.idh.2021.03.002
pmc: PMC8011642
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

189-197

Informations de copyright

Copyright © 2021 Australasian College for Infection Prevention and Control. Published by Elsevier B.V. All rights reserved.

Références

J Hosp Infect. 2021 Mar;109:40-43
pubmed: 33169676
JAMA Netw Open. 2020 Dec 1;3(12):e2033324
pubmed: 33337490
Euro Surveill. 2020 Apr;25(13):
pubmed: 32265003
Healthcare (Basel). 2016 Aug 01;4(3):
pubmed: 27490580
JAMA. 2020 Jul 28;324(4):335-336
pubmed: 32525519
PLoS Med. 2020 Oct 15;17(10):e1003354
pubmed: 33057373
J Infect. 2012 Mar;64(3):319-24
pubmed: 22198739
Vaccine. 2020 Oct 21;38(45):7002-7006
pubmed: 32988688
Curr Opin Infect Dis. 2008 Aug;21(4):337-43
pubmed: 18594283
Vaccine. 2010 Aug 23;28(37):5931-3
pubmed: 20637760
Pragmat Obs Res. 2020 Oct 29;11:103-109
pubmed: 33154695
J Hosp Infect. 2021 Feb;108:168-173
pubmed: 33259883
Int J Environ Res Public Health. 2021 Mar 08;18(5):
pubmed: 33800187
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):472-476
pubmed: 32298249
Eur J Epidemiol. 2020 Aug;35(8):775-779
pubmed: 32785815
Ann Intern Med. 2021 Jun;174(6):882-885
pubmed: 33556267
Vaccine. 2020 Oct 21;38(45):7049-7056
pubmed: 32980199
JAMA. 2020 Jun 23;323(24):2458-2459
pubmed: 32421155
Transl Behav Med. 2020 Oct 8;10(4):850-856
pubmed: 32910819
Vaccine. 2020 Nov 10;38(48):7654-7658
pubmed: 33077302
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):477-481
pubmed: 32298247
JAMA Netw Open. 2021 Mar 1;4(3):e215344
pubmed: 33755164
Aust J Gen Pract. 2020 Oct;49(10):625-629
pubmed: 33015676
Anaesthesia. 2020 Aug;75(8):1086-1095
pubmed: 32311771
Bull World Health Organ. 2022 Feb 01;100(2):127-134
pubmed: 35125537
J Infect. 2010 Sep;61(3):252-8
pubmed: 20600304
Clin Infect Dis. 2020 Dec 15;71(12):3182-3187
pubmed: 32594160
Pediatr Infect Dis J. 2012 Jun;31(6):623-5
pubmed: 22333705

Auteurs

Helena C Maltezou (HC)

Directorate of Research, Studies, and Documentation, National Public Health Organization, Athens, 11523, Greece. Electronic address: helen-maltezou@ath.forthnet.gr.

Androula Pavli (A)

Department for Travel Medicine, National Public Health Organization, Athens, 11523, Greece.

Xanthi Dedoukou (X)

National Public Health Organization, Athens, 11523, Greece.

Theano Georgakopoulou (T)

Directorate of Epidemiological Surveillance and Interventions for Infectious Diseases, National Public Health Organization, Athens, 11523, Greece.

Vasilios Raftopoulos (V)

HIV Surveillance Department, National Public Health Organization, Athens, 11523, Greece.

Ioannis Drositis (I)

Medical Oncology Department, Venizeleio-Pananeio General Hospital, Heraklion, 71409, Greece.

Emmanouil Bolikas (E)

Infection Control Committee, Venizeleio-Pananeio General Hospital, Heraklion, 71409, Greece.

Caterina Ledda (C)

Occupational Medicine, Department of Clinical and Experimental Medicine, University of Catania, Catania, 95124, Italy.

Georgios Adamis (G)

First Department of Internal Medicine, Infectious Diseases Unit, Gennimatas General Hospital, Athens, 11527, Greece.

Andronikos Spyrou (A)

First Department of Internal Medicine, Infectious Diseases Unit, Gennimatas General Hospital, Athens, 11527, Greece.

Eleni Karantoni (E)

Medical Directorate, Hellenic Air Force General Staff, Athens, 11525, Greece.

Maria N Gamaletsou (MN)

Pathophysiology Department, Medical School, National and Kapodistrian University of Athens, 11527, Greece.

Dimitra Maria Koukou (DM)

First Department of Pediatrics, University of Athens, Aghia Sophia Children's Hospital, Athens, 11527, Greece.

Athanasia Lourida (A)

Infection Prevention and Control Committee, Aghia Sofia Children's Hospital, Athens, 11527, Greece.

Nikolaos Moussas (N)

Internal Medicine and Infectious Diseases Clinic, Iatriko Athinon General Hospital, Athens, 11523, Greece.

Vasilios Petrakis (V)

Second Department of Internal Medicine, Medical School, Democritus University of Thrace, Alexandroupolis, 68100, Greece.

Periklis Panagopoulos (P)

Second Department of Internal Medicine, Medical School, Democritus University of Thrace, Alexandroupolis, 68100, Greece.

Dimitrios Hatzigeorgiou (D)

Medical Directorate, Hellenic Air Force General Staff, Athens, 11525, Greece.

Maria Theodoridou (M)

First Department of Pediatrics, University of Athens, Aghia Sophia Children's Hospital, Athens, 11527, Greece.

Marios Lazanas (M)

Internal Medicine and Infectious Diseases Department, Iaso Maternity Hospital, Athens, 11523, Greece.

Panagiotis Gargalianos (P)

Internal Medicine and Infectious Diseases Clinic, Iatriko Athinon General Hospital, Athens, 11523, Greece.

Nikolaos V Sipsas (NV)

Pathophysiology Department, Medical School, National and Kapodistrian University of Athens, 11527, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH